Heron Therapeutics (HRTX) Receivables - Other (2020 - 2024)
Historic Receivables - Other for Heron Therapeutics (HRTX) over the last 5 years, with Q4 2024 value amounting to $263000.0.
- Heron Therapeutics' Receivables - Other fell 1516.13% to $263000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $263000.0, marking a year-over-year decrease of 1516.13%. This contributed to the annual value of $263000.0 for FY2024, which is 1516.13% down from last year.
- As of Q4 2024, Heron Therapeutics' Receivables - Other stood at $263000.0, which was down 1516.13% from $310000.0 recorded in Q4 2023.
- Over the past 5 years, Heron Therapeutics' Receivables - Other peaked at $6.2 million during Q4 2022, and registered a low of $245000.0 during Q4 2021.
- Moreover, its 5-year median value for Receivables - Other was $310000.0 (2023), whereas its average is $1.5 million.
- In the last 5 years, Heron Therapeutics' Receivables - Other skyrocketed by 242938.78% in 2022 and then tumbled by 9499.76% in 2023.
- Heron Therapeutics' Receivables - Other (Quarter) stood at $334000.0 in 2020, then dropped by 26.65% to $245000.0 in 2021, then soared by 2429.39% to $6.2 million in 2022, then crashed by 95.0% to $310000.0 in 2023, then decreased by 15.16% to $263000.0 in 2024.
- Its Receivables - Other was $263000.0 in Q4 2024, compared to $310000.0 in Q4 2023 and $6.2 million in Q4 2022.